顶刊论文（社媒热度）精选评分81
Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study.
No English body on site. Use the original article link above.
No English body on site. Use the original article link above.